Phosphorylated AKT Protein Is Overexpressed in Human Peripheral T-cell Lymphomas and Predicts Decreased Patient Survival

被引：17
作者：
Cai, Qingqing [2 ]
Deng, Haixia [2 ]
Xie, Dan [2 ]
Lin, Tianxin [3 ,4 ]
Lin, Tongyu [1 ,2 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 2, State Key Lab Oncol So China, Guangzhou 510060, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Urol, Guangzhou 510060, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 2, Lin Bai Xin Med Res Ctr, Guangzhou 510060, Guangdong, Peoples R China
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2012年 / 12卷 / 02期
关键词：
Immunohistochemistry; Peripheral T-cell lymphoma; Phosphorylated AKT; Prognosis; LUNG-CANCER CELLS; NF-KAPPA-B; CHEMOTHERAPEUTIC RESISTANCE; MULTIDRUG-RESISTANCE; PI3K/AKT PATHWAY; PROSTATE-CANCER; KINASE-B; ACTIVATION; EXPRESSION; PTEN;
D O I：
10.1016/j.clml.2011.12.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The expression of phosphorylated AKT (pAKT) in peripheral T-cell lymphomas (PTCL) and its clinical significance were studied. We detected pAKT expression by using the immunohistochemical method in 106 cases of PTCL. Positive pAKT expression was detected in 49.1% of patients, was negatively correlated with overall response rate, and predicted decreased progression-free survival and/or overall survival. Our results suggest that pAKT expression is an independent prognostic factor for PTCL. Background: The AKT signaling pathway controls the survival and growth of human cancer cells. The purpose of this study was to investigate the expression dynamics of phosphorylated AKT (pAKT) in peripheral T-cell lymphoma (PTCL) and its clinical significance. Materials and Methods: Immunohistochemistry was performed to examine the pAKT expression in 106 PTCL cases. pAKT expression and its association with clinicopathologic characteristics of a patient with PTCL were analyzed. Results: A total of 106 samples were tested, and 52 (49.1%) were positive for pAKT. There was significant positive correlation between pAKT expression and higher levels of lactic dehydrogenase (P<.05), whereas positive pAKT expression was negatively correlated with patients' overall response rate (P<.05). Further multivariate analysis revealed that positive pAKT expression predicted decreased progression-free survival and/or overall survival (P<.05). Conclusion: Analysis of our results suggest that pAKT expression, as examined by immunohistochemistry, is an independent prognostic factor for PTCL. The clinical value of pAKT expression analysis in PTCL is worthy of further clinical investigations.
引用
收藏
页码：106 / 112
页数：7
相关论文
共 35 条
[11]   Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas [J].
Cheson, BD ;
Horning, SJ ;
Coiffier, B ;
Shipp, MA ;
Fisher, RI ;
Connors, JM ;
Lister, TA ;
Vose, J ;
Grillo-López, A ;
Hagenbeek, A ;
Cabanillas, F ;
Klippensten, D ;
Hiddemann, W ;
Castellino, R ;
Harris, NL ;
Armitage, JO ;
Carter, W ;
Hoppe, R ;
Canellos, GP .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1244-1253
[12]  
Clark AS, 2003, CANCER RES, V63, P780
[13]  
Clark AS, 2002, MOL CANCER THER, V1, P707
[14]   PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies [J].
Dahia, PLM ;
Aguiar, RCT ;
Alberta, J ;
Kum, JB ;
Caron, S ;
Sill, H ;
Marsh, DJ ;
Ritz, J ;
Freedman, A ;
Stiles, C ;
Eng, C .
HUMAN MOLECULAR GENETICS, 1999, 8 (02) :185-193
[15]   Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study [J].
Gallamini, A ;
Stelitano, C ;
Calvi, R ;
Bellei, M ;
Mattei, D ;
Vitolo, U ;
Morabito, F ;
Martelli, M ;
Brusamolino, E ;
Iannitto, E ;
Zaja, F ;
Cortelazzo, S ;
Rigacci, L ;
Devizzi, L ;
Todeschini, G ;
Santini, G ;
Brugiatelli, M ;
Federico, M .
BLOOD, 2004, 103 (07) :2474-2479
[16]   PI3K/Akt inhibition modulates multidrug resistance and activates NF-κB in murine lymphoma cell lines [J].
Garcia, Mariana G. ;
Alaniz, Laura D. ;
Cordo Russo, Rosalia I. ;
Alvarez, Elida ;
Hajos, Silvia E. .
LEUKEMIA RESEARCH, 2009, 33 (02) :288-296
[17]   PTEN, pAKT, and pmTOR Expression and Subcellular Distribution in Primary Renal Cell Carcinomas and Their Metastases [J].
Hager, Martina ;
Haufe, Heike ;
Lusuardi, Lukas ;
Schmeller, Nikolaus ;
Kolbitsch, Christian .
CANCER INVESTIGATION, 2011, 29 (07) :427-438
[18]   High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy [J].
Hasselblom, Sverker ;
Hansson, Ulrika ;
Olsson, Markus ;
Toren, Leif ;
Bergstrom, Anders ;
Nilsson-Ehle, Herman ;
Andersson, Per-Ola .
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (04) :560-568
[19]   Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type [J].
Huang, J. J. ;
Jiang, W. Q. ;
Lin, T. Y. ;
Huang, Y. ;
Xu, R. H. ;
Huang, H. Q. ;
Li, Z. M. .
ANNALS OF ONCOLOGY, 2011, 22 (01) :149-155
[20]   Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer [J].
Kreisberg, JI ;
Malik, SN ;
Prihoda, TJ ;
Bedolla, RG ;
Troyer, DA ;
Kreisberg, S ;
Ghosh, PM .
CANCER RESEARCH, 2004, 64 (15) :5232-5236
1234